LAB eN2 brings
innovation to life
LAB eN2 brings
innovation to life
LAB eN² (pronounced Lab ee – en – squared) combines the power of two world class companies, Novo Nordisk and Evotec, into a novel partnership designed to accelerate the translation of innovative academic drug discovery ideas from bench to bedside!
Our model aims to bring life-changing therapies based on your discoveries to people living with cardiometabolic conditions and rare blood disorders in an efficient and expedited manner.
![Content_1493932277](https://laben2.com/wp-content/uploads/Content_1493932277-800x577.jpg)
![Content_735335617](https://laben2.com/wp-content/uploads/Content_735335617-800x577.jpg)
![Content_1332632720](https://laben2.com/wp-content/uploads/Content_1332632720-800x577.jpg)